This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
He has the right vision, skills and experience to lead our R&D organisation,” commented Rob Michael, Chief Executive Officer, AbbVie. “As AbbVie’s Chief Scientific Officer, Dr Thakkar will continue to build momentum across discovery and all stages of development to fully realise the potential of our diverse pipeline.
Globus Medical (NYSE: GMED), a leading musculoskeletal solutions company, and NUVASIVE (NASDAQ: NUVA), the leader in spine technology innovation, today announced they have entered into a definitive agreement to combine in an all-stock transaction.
J&J has a long history of leading the way in the development of surgical instruments and surgical equipment, dating back over 130 years. Boston Scientific is among the world’s leading surgical equipment manufacturers, treating approximately 22 million patients every year. Boston Scientific.
FINN Partners , an independent marketing and communications agency, is expanding its global footprint even further with the addition of SPAG , a leading, Asia-headquartered, health-sector communications and marketing firm with offices in Bangalore, Delhi, Indonesia, Malaysia, Mumbai, the Philippines, and Singapore.
Can you share an update on the clinical trial for your lead candidate? Following his graduate studies, Dr Hoppin was an Alexander von Humboldt Fellow at the Research Center Jülich, Center for Electronics in Germany from 2003 to 2005. Barrett at the Center for Gamma Ray Imaging.
Dry eye syndrome (DES) is an indication whose mainstay treatment has been dominated by Allergan’s Restasis (cyclosporine ophthalmic emulsion 0.05%) ever since its launch in 2003 in the US.
Self-stigma is also prevalent and hinders individuals from getting tested, starting pre‑exposure prophylaxis (PrEP) (if they’re HIV negative), seeking the lifesaving treatments they need (if they’re HIV positive), and can lead to isolation and depression. References 1. World Health Organization. The Global Health Observatory. Internet] 2023.
Targeting toxic species of Abeta, such as multimers (with aducanumab and lecanemab) or pyroglutamate Abeta3-42 (with donanemab), induced significant removal of Abeta plaque load in the brains of Alzheimer’s patients, leading to the delay in cognitive decline. Andrea Pfeifer, PhD In 2003, Andrea Pfeifer co-founded AC Immune SA.
Production and value creation can be regionalised and decentralised, which could lead to a more resilient economic structure. During his time at Genentech Stefan has advanced several small molecules and new modalities (antibody‑drug conjugates, oligonucleotides and peptides) into the clinic as lead chemist and technical development leader.
One in three people is expected to develop a neurological condition in their lifetime, and neurological diseases are the leading cause of disability. since 2007, and he previously held the position of chief operating officer when he first joined the company in 2003. Today, the urgency has never been more apparent.
Thanks to its success, two researchers, Lauterbur and Mansfield , were awarded the 2003 Nobel Prize in Medicine, and millions of patients have their lives saved or significantly improved. Poor identification of the type of innovation can lead to a poor understanding of its characteristics and full potential.
According to a 16-year analysis by the National Library of Medicine , the total average residency case volumes have increased 36% from 2003 to 2016. This change will only lead to gastrointestinal endoscopies getting easier and saving time for both the doctors and the patient. The current valuation is 15.12 Final Thoughts.
Niall Brennan , a leading expert on healthcare data use, privacy, and policy, moderated the discussion. Niall was also responsible for leading CMS’ first price transparency efforts, which are the foundation for the policies we have in place today. But first, let’s introduce the speakers!
Niall Brennan , a leading expert on healthcare data use, privacy, and policy, moderated the discussion. Niall was also responsible for leading CMS’ first price transparency efforts, which are the foundation for the policies we have in place today. But first, let’s introduce the speakers!
.” By the early 2000s AstraZeneca had already realised the critical importance of biotechnology, making a number of strategic investments in biotech companies, Abgenix in 2003, Cambridge Antibody Technology in 2006 and culminating in its acquisition of US biotech firm, Medimmune in April 2007 for £15bn.
Yet, VMS leads the clinical educator market in patient confidence to start and maintain therapy. Our custom system was built in 2003,” said Brochhagen. VMS BioMarketing strives to make real, personal connections that help patients engage in their treatment regimen. This kind of patient-centered approach isn’t easy.
Tune in to our latest podcast as Lee Aase, founder of HELPCare, LLC, shares how he transitioned from his pioneering social media work at Mayo Clinic to lead an innovative membership-based direct-to-patient healthcare business. Struggling with burnout while maintaining high-quality healthcare services that patients love? It was scary.
AstraZeneca ’s cholesterol drug Crestor (rosuvastatin) was approved in 2003 in the US but only approved in Germany in 2008. The World Health Organization (WHO) reports that cardiovascular disease is the major leading cause of death, with 17.9 The company now faces a highly competitive generics market for its lead drug.
A few decades ago, gathering genetic data on the scale of the 100,000 Genomes Project would have been unthinkable – it was only in 2003 that the entire human genome was mapped. Support for Our Future Health from leading health charities makes sense when it is understood how poorly understood many prominent diseases are.
Sientra delivers leading transformative treatments and technologies concentrated on advancing the art of plastic surgery and making a difference in users lives. Location: California Website: sientra.com Established year: 2003 Revenue: $90.3 Sientra is a medical aesthetics establishment with body contouring creations and implants.
This may lead to longer development timelines and higher costs for life science companies. Potential requirements for ATMP developers to implement new systems for tracking and tracing the use of SoHOs throughout the development process. Cited 2023Mar].
As a serial CEO leading different Fortune 500s as well as chairing the selection committee meetings of the prestigious CEO of the Year program , what are the top skills aspiring CEOs need to secure as they pursue their career aspirations? Especially in turnaround situations, its often crucial to lead change from the top line.
Since the government first created a Part D benefit with the Medicare Modernization Act of 2003 (MMA) , Democrats have agitated for greater governmental input into the cost of prescription drugs for Medicare beneficiaries. Pillo, Senior Healthcare Research and Data Analyst; and Paula Wade, Lead Healthcare Research and Data Analyst.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content